NEW YORK (GenomeWeb) – In its Form 10-Q for the first quarter of 2017 this week, Laboratory Corporation of America said that the US Securities and Exchange Commission subpoenaed Sequenom on Feb. 7. The subpoena was issued as part of an investigation by the SEC into trading activity of Sequenom's shares related to the July 2016 announcement that it was being acquired by LabCorp. The commission issued a similar subpoena to LabCorp on March 7, the company said, adding that it is cooperating with the requests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.